Neuroendocrine tumors exhibit diverse clinical outcomes, and several recent studies have demonstrated that tumor histology, which incorporates assessments of tumor differentiation, tumor grade, mitotic rate, and proliferative index, can be associated with clinical outcomes and overall survival.